Gencurix
Gencurix is bio healthcare company specializing in molecular diagnostics based on PCR(Polymerase Chain Reaction) technology. Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome-the individual's genetic code and how their cells express their genes as proteins-by applying molecular biology to medical testing. Gencurix develops and produce various diagnostics kit gathering professional experts in molecular diagnostics area. Gencurix's business areas are early diagnostics, multigene testing, companion diagnostics and monitoring for various kinds of cancers. They have recently developed COVID-19 diagnostic kit and shipped them all over the world.
About Gencurix
Founded
2011Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$56MCategory
Industry Group
Surgical, Medical, and Dental Instruments and SuppliesIndustry
BiotechnologyLocation
City
SeoulState
SeoulCountry
South KoreaGencurix
Find your buyer within Gencurix